首页 > 最新文献

Scandinavian journal of respiratory diseases. Supplementum最新文献

英文 中文
Pathophysiologic mechanisms in asthma. Molecular and pharmacological aspects. 哮喘的病理生理机制。分子和药理学方面。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
S Norn, P Stahl Skov
{"title":"Pathophysiologic mechanisms in asthma. Molecular and pharmacological aspects.","authors":"S Norn, P Stahl Skov","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"25-32"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11306881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Historical aspects of anticholinergic treatment of obstructive airways disease. 抗胆碱能治疗阻塞性气道疾病的历史方面。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
C W Hertz
{"title":"Historical aspects of anticholinergic treatment of obstructive airways disease.","authors":"C W Hertz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"105-9"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11582381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchial carcinoma. II. Quantitative measurements of the quality of survival. A prospective randomized study of the result of therapy in inoperable patients with advanced disease. 支气管癌。2生存质量的定量测量。一项晚期疾病不能手术患者治疗结果的前瞻性随机研究。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
E Nõu

Forty-eight bronchial carcinoma patients in clinicoanatomical stage 4 of the disease (advanced disease) were randomly assigned to groups for radiotherapy, chemotherapy (cyclophosphamide) and placebo treatment, respectively. The results were assessed by the survival time and quality of survival. The median survival time was 4.7 months for radiotherapy, 4.7 months for cyclophosphamide and 1.7 months for placebo. The median total sum of vitagram points was 28.1 for radiotherapy, 20.7 for cyclophosphamide and 6.8 for placebo. When calculated per month, the median sum of vitagram points was 5.9 for radiotherapy, 5.7 for cyclophosphamide and 4.8 for placebo. Statistically the results give no reason to believe that placebo is better than radiotherapy, but it cannot be excluded that radiotherapy patients could have a much longer survival. As for cyclophosphamide versus radiotherapy, the differences are to uncertain for any conclusion to be drawn.

48例支气管癌临床解剖期4期(晚期)患者随机分为放疗组、化疗组(环磷酰胺)组和安慰剂组。以生存时间和生存质量评价结果。放疗组的中位生存时间为4.7个月，环磷酰胺组为4.7个月，安慰剂组为1.7个月。放疗组的维格图积分中位数为28.1，环磷酰胺组为20.7，安慰剂组为6.8。当每月计算时，放疗组的维格图积分中位数为5.9，环磷酰胺组为5.7，安慰剂组为4.8。统计结果没有理由相信安慰剂比放疗更好，但不能排除放疗患者可能有更长的生存期。至于环磷酰胺与放疗的区别，尚不确定，无法得出任何结论。
{"title":"Bronchial carcinoma. II. Quantitative measurements of the quality of survival. A prospective randomized study of the result of therapy in inoperable patients with advanced disease.","authors":"E Nõu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Forty-eight bronchial carcinoma patients in clinicoanatomical stage 4 of the disease (advanced disease) were randomly assigned to groups for radiotherapy, chemotherapy (cyclophosphamide) and placebo treatment, respectively. The results were assessed by the survival time and quality of survival. The median survival time was 4.7 months for radiotherapy, 4.7 months for cyclophosphamide and 1.7 months for placebo. The median total sum of vitagram points was 28.1 for radiotherapy, 20.7 for cyclophosphamide and 6.8 for placebo. When calculated per month, the median sum of vitagram points was 5.9 for radiotherapy, 5.7 for cyclophosphamide and 4.8 for placebo. Statistically the results give no reason to believe that placebo is better than radiotherapy, but it cannot be excluded that radiotherapy patients could have a much longer survival. As for cyclophosphamide versus radiotherapy, the differences are to uncertain for any conclusion to be drawn.</p>","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"104 ","pages":"83-106"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11502969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchial mucus in obstructive lung disease. 支气管粘液与阻塞性肺疾病的关系。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
M T Lopez-Vidriero
{"title":"Bronchial mucus in obstructive lung disease.","authors":"M T Lopez-Vidriero","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"33-7"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11512596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspects on bronchial beta2-receptor tolerance. 支气管β - 2受体耐受性的几个方面。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
S Larsson
{"title":"Aspects on bronchial beta2-receptor tolerance.","authors":"S Larsson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"84-9"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11258263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SCH 1000 in psychogenic asthma. 心因性哮喘SCH 1000。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
A S Rebuck, H I Marcus

The effects of a beta 2-sympathomimetic (salbutamol or fenoterol) and the anticholinergic SCH 1000 administered both in combination and with placebo were compared in a double-blind random crossover design. Thirty-three patients with atopic, non-atopic and psychogenic asthma were studied. After inhalation of the sympathomimetic in combination with SCH 1000 or placebo the increase in FEV1 was significantly better for three hours (p less than 0.05) than after inhalation of SCH 1000 alone. There was no difference in the response to SCH 1000 in the atopic or non-atopic groups. However, in patients with a major psychogenic component to their asthma the FEV1 response to SCH 1000 was significantly better (p less than 0.05) than in other asthmatics from four to seven hours past inhalation. These findings suggest that SCH 1000 might be a valuable therapeutic agent in patients with psychogenic asthma.

在双盲随机交叉设计中比较β 2-拟交感神经药物(沙丁胺醇或非诺特罗)和抗胆碱能药物SCH 1000联合使用和与安慰剂的效果。对33例特应性、非特应性及心因性哮喘患者进行研究。拟交感神经制剂与SCH 1000或安慰剂联合吸入3小时后，FEV1的增加明显优于单独吸入SCH 1000 (p < 0.05)。特应性组和非特应性组对SCH 1000的反应无差异。然而，在哮喘主要心理因素的患者中，吸入SCH 1000后4至7小时的FEV1反应明显优于其他哮喘患者(p < 0.05)。这些结果提示，SCH 1000可能是一种有价值的治疗心因性哮喘的药物。
{"title":"SCH 1000 in psychogenic asthma.","authors":"A S Rebuck,&nbsp;H I Marcus","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effects of a beta 2-sympathomimetic (salbutamol or fenoterol) and the anticholinergic SCH 1000 administered both in combination and with placebo were compared in a double-blind random crossover design. Thirty-three patients with atopic, non-atopic and psychogenic asthma were studied. After inhalation of the sympathomimetic in combination with SCH 1000 or placebo the increase in FEV1 was significantly better for three hours (p less than 0.05) than after inhalation of SCH 1000 alone. There was no difference in the response to SCH 1000 in the atopic or non-atopic groups. However, in patients with a major psychogenic component to their asthma the FEV1 response to SCH 1000 was significantly better (p less than 0.05) than in other asthmatics from four to seven hours past inhalation. These findings suggest that SCH 1000 might be a valuable therapeutic agent in patients with psychogenic asthma.</p>","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"186-91"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of ipratropium bromide and an oral anticholinergic drug in chronic bronchitis. 异丙托溴铵与口服抗胆碱能药物治疗慢性支气管炎的比较。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
A J Otto
{"title":"Comparison of ipratropium bromide and an oral anticholinergic drug in chronic bronchitis.","authors":"A J Otto","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"151-3"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined effect of an anticholinergic drug ipratropium bromide and disodium cromoglycate in exercise induced asthma. 抗胆碱能药物异丙托溴铵与甘糖酸二钠联合治疗运动性哮喘的疗效观察。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
F V Rasmussen, L Madsen, A Bundgaard
{"title":"Combined effect of an anticholinergic drug ipratropium bromide and disodium cromoglycate in exercise induced asthma.","authors":"F V Rasmussen,&nbsp;L Madsen,&nbsp;A Bundgaard","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"159-62"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circadian rhythmicity in medicine with special regard to asthmatic patients. 医学上的昼夜节律性，特别是哮喘患者。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
K Retiene
{"title":"Circadian rhythmicity in medicine with special regard to asthmatic patients.","authors":"K Retiene","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"55-61"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11434448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ipratropium bromide and fenoterol in pulmonary tuberculosis. 异丙托溴铵和非诺特罗治疗肺结核。
Scandinavian journal of respiratory diseases. Supplementum
Pub Date : 1979-01-01
Y Salorinne, H Poppius, B Stenius-Aarniala
{"title":"Ipratropium bromide and fenoterol in pulmonary tuberculosis.","authors":"Y Salorinne,&nbsp;H Poppius,&nbsp;B Stenius-Aarniala","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"183-5"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Scandinavian journal of respiratory diseases. Supplementum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1